These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2190140

  • 1. New vaccines against Haemophilus influenzae type b.
    Shapiro ED.
    Pediatr Clin North Am; 1990 Jun; 37(3):567-83. PubMed ID: 2190140
    [Abstract] [Full Text] [Related]

  • 2. Prevention of Haemophilus influenzae type b disease.
    Santosham M.
    Vaccine; 1993 Jun; 11 Suppl 1():S52-7. PubMed ID: 8447177
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 6. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
    Eskola J, Takala AK, Käyhty H.
    Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Jan 11; 40(RR-1):1-7. PubMed ID: 1899280
    [Abstract] [Full Text] [Related]

  • 9. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
    Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI.
    Pediatr Infect Dis J; 1993 Jun 11; 12(6):484-92. PubMed ID: 8345981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J, Peltola H, Käyhty H, Takala AK, Mäkelä PH.
    J Infect Dis; 1992 Jun 11; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age.
    Loughlin AM, Marchant CD, Lett S, Shapiro ED.
    Pediatr Infect Dis J; 1992 May 11; 11(5):374-9. PubMed ID: 1630857
    [Abstract] [Full Text] [Related]

  • 15. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
    Carlsson RM, Claesson BA, Iwarson S, Lagergård T, Käyhty H.
    Pediatr Infect Dis J; 1994 Jan 11; 13(1):27-33. PubMed ID: 8170729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH, Eskola J, Peltola H, Takala AK, Käyhty H.
    Pediatrics; 1990 Apr 11; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.